Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CartiPRO vs Synovian in Knee Osteoarthritis
NCT07267793Active, not recruiting
- Sponsor
- Dalim Tissen Co., Ltd.
- Start
- Jul 2025
- Primary completion
- Dec 2026
- Modality
- Recombinant Proteins and Enzymes, Device-based Delivery
- Countries
- 1
01
Overview
Randomised, single-blind trial of CartiPRO in knee osteoarthritis (OA) (2 arms), sponsored by Dalim Tissen Co., Ltd. Primary endpoint: Weight-Bearing Pain Visual Analogue Scale at 12 weeks. Started Jul 2025; status: active, not recruiting.
02
Drugs
CartiPRO
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT07267793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07267793.